08:50 EDT Adverum Biotechnologies (ADVM) trading resumes
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADVM:
- Eli Lilly to acquire Adverum Biotechnologies for up to $12.47 per share
- Adverum Biotechnologies trading halted, news pending
- Positive Outlook for Adverum Biotechnologies: Buy Rating Based on Promising ixo-vec Therapy and Strategic Financing Plans
- 3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
- Buy Rating for Adverum Biotechnologies: Promising Phase 3 Trial Progress and Financial Resilience